The document discusses guidelines and recommendations for weaning patients from mechanical ventilation and discontinuing ventilator support. Some key points covered include:
- Weaning involves gradually reducing ventilatory support as a patient's condition improves to avoid complications of prolonged ventilation.
- Readiness for weaning depends on recovery from the underlying medical issues, overall clinical condition, and psychological state.
- Spontaneous breathing trials are recommended to assess a patient's ability to breathe independently without ventilator support.
- Factors like ventilator mode, oxygen needs, airway protection, and non-respiratory medical conditions must be considered during the weaning process.
- Protocols and guidelines aim to standard
An excellent tool to treat refractory hypoxia. Target audience are ICU junior physicians and Respiratory Therapists. It will take away the fear of "What is APRV?" from your hearts and you will feel ready to give it a try.
A mechanical ventilator is a machine that helps a patient breathe (ventilate) when they are having surgery or cannot breathe on their own due to a critical illness. The patient is connected to the ventilator with a hollow tube (artificial airway) that goes in their mouth and down into their main airway or trachea
HERE IS A SEMINAR BASED ON ALL THE NEWER MODES OF MECHANICAL VENTILATION .
MY SINCERE APOLOGIES , BECAUSE I HAD TO TAKE INFORMATION FROM OTHERS SLIDES TOO , SINCE THERE IS VERY LESS INFORMATION AVAILABLE ABOUT THIS TOPIC
Weaning and Discontinuing Ventilatory Supporthanaa
1) The epidemiology of weaning
2) Evidence-based weaning guidelines
3) The pathophysiology of weaning failure
4) Is there a role for different ventilator modes in weaning?
An excellent tool to treat refractory hypoxia. Target audience are ICU junior physicians and Respiratory Therapists. It will take away the fear of "What is APRV?" from your hearts and you will feel ready to give it a try.
A mechanical ventilator is a machine that helps a patient breathe (ventilate) when they are having surgery or cannot breathe on their own due to a critical illness. The patient is connected to the ventilator with a hollow tube (artificial airway) that goes in their mouth and down into their main airway or trachea
HERE IS A SEMINAR BASED ON ALL THE NEWER MODES OF MECHANICAL VENTILATION .
MY SINCERE APOLOGIES , BECAUSE I HAD TO TAKE INFORMATION FROM OTHERS SLIDES TOO , SINCE THERE IS VERY LESS INFORMATION AVAILABLE ABOUT THIS TOPIC
Weaning and Discontinuing Ventilatory Supporthanaa
1) The epidemiology of weaning
2) Evidence-based weaning guidelines
3) The pathophysiology of weaning failure
4) Is there a role for different ventilator modes in weaning?
Predictors of weaning from mechanical ventilator outcomeMuhammad Asim Rana
This is a very useful presentation for respiratory therapists and ICU and Emergency physicians. Intended to teach how to assess you patient's readiness for weaning from mechanical ventilator and successful separation from machine.
Weaning from mechanical ventilation , also called ventilator liberation, refers to the process of the patient assuming more and more of the work of breathing and finally demonstrating that ventilator support is no longer required.
Simply it means the process of withdrawing mechanical ventilatory support and transferring the work of breathing from the ventilator to the patient . Weaning can be accomplished with an endotrachel tube ( ETT) or a tracheostomy tube in place.
In the case of the ETT, the final step in the process is the removal of the tube( extubation). With a tracheostomy, the final step may be the ability to breath spontaneously for a designated period of time with the tube in place.
Weaning success is defined as absence of ventilatory support 48 hours following the extubation.
While the spontaneous breaths are unassisted by mechanical ventilation, supplemental oxygen, bronchodilators, low level pressure support ventilation or continuous positive airway pressure (CPAP) may be used to support and maintain adequate spontaneous ventilation and oxygenation.
Purpose
The purpose is to assess the probability that mechanical ventilation can be successfully discontinued.as
75% of mechanically ventilated patients are easy to be weaned off the ventilator with simple process.
10-15% of patients require a use of a weaning protocol over a 24-72 hours.
5-10% require a prolonged weaning plan.
1% of patients become dependent on chronic mechanical ventilation.
Indication
Improvement of the cause of respiratory failure.
Absence of major system dysfunction.
Appropriate level of oxygenation.
Adequate ventilatory status.
Intact airway protective mechanism.
Contraindication
Altered sensorium either drowsiness or restlessness.
Spo2 ˂90%
Rising PaCO2 with drop in PH
Tachypnoea ˃35/ min
Tachycardia ˃120 /min
Drop in systolic blood pressure
Sweating
Cold clammy skin
Signs of diaphragmatic weakness
Paradoxical abdominal wall movement
Assessment of readiness for weaning
Hemodynamic stability
Minimum inotropic support
Adequate cardiac output
Afebrile
Hematocrite greater than 25%
Respiratory stability
Improved chest x-ray
Arterial oxygen tension (PaO2) greater than 60mm Hg with fraction of inspired oxygen ( FiO2) less than 0.5
PaO2/FiO2 greater than 300 mm Hg
Positive end expiratory pressure (PEEP) less than 0-5 cm H2O
Vital capacity (VC) 10-15ml/kg
Spontaneous tidal volume (VT) 5ml/Kg
Respiratory rate less than 30 breaths/mim
Minute ventilation 5-10 L/min
Negative inspiratory pressure greater than -20cm H2O
Rapid shallow breathing index (RSBI) less than 105
metabolic factors stable
Electrolytes within normal range.
ABGs( Arterial blood gases) normalized
Other
Adequate management of pain and anxiety.
Patient is well rested
Weaning criteria
Weaning criteria are used to evaluate the readiness of a patient for a weaning trial and the likelihood of weaning success.
Clinical criteria
Ventilatory criteria
Oxygenation criteria
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
2. DEF:
Gradual reduction of ventilatory support from a patient whose condition
is improving.
Other terms
Discontinuation
Gradual withdrawl
Liberation
3. Disadvantages of prolonged ventilation
Nosocomial Pneumonia (VAP)
Stretch injury and barotrauma
Airway trauma
Prolonged Sedation
Obvious increase in associated cost
Ventilator dependency
4.
5. Decision to wean
recovery from the medical problems thatimposed the need for mechanical
ventilation.
Overall clinical condition.
Psychological state
7. Weaning techniques
About 80% of patients requiring temporary mechanical ventilation do not
require a gradual withdrawal process, and can be disconnected within a few
hours or days of initial support.
First : patients may require ventilatory support during weaning.
Second : Second, supplemental oxygen and positive end-expiratory pressure
(PEEP) may be required to support oxygenation.
Third : some individuals may require maintenance of the artificial airway even
after ventilatory support has been discontinued.
Fourth : many patients require more than one of these therapeutic
interventions.
8. METHODS OF TITRATING VENTILATOR
SUPPORT DURING WEANING
intermittent mandatory ventilation (IMV)
Pressure support ventilation (PSV)
T-piece weaning
weaning process was inordinately prolonged with IMV compared with other
weaning techniques.
10. Components of Ventilatory
Management and Discontinuation
• Positive pressure ventilation (PPV) to support breathing
• Supplemental oxygen and positive end-expiratory pressure (PEEP) to
improve oxygenation
• Artificial airway to protect the airway and to provide
invasive ventilation
• Airway management to maintain clear airways (i.e.,
suctioning; humidification and warming of inspired air;
bronchial hygiene; and aerosolized medications)
• Therapy directed at the primary disease process
11. Intermittent mandatory
ventilation (IMV/SIMV)
PSV can be added to unload
the spontaneous breaths and
reduce the patient’s WOB
through the ventilator system,
circuit, and artificial airway ,
which in turn can help prevent
excessive fatigue. (5
to 10 cm H2O)
PEEP (5 to 10 cm H2O)
12.
13.
14. Pressure support ventilation
PSV- patient triggered, pressure limited and flow cycled.
5 to 15 cm of H2O
When pressure support is reduced to about 5 cm H2O, the pressure level is
not high enough to contribute significantly to ventilatory support
17. Automatic Tube Compensation
Therefore a fixed level of pressure support can result in too little support when
inspiratory flow is high, or too much support when inspiratory flow is low.
variable PSV with variable inspiratory flow compensation.
19. Automode and Variable Pressure Support/
Variable Pressure Control
Usefull in a postoperative patient is still recovering from the effects of anesthesia
ventilator operator has selected volume-controlled continuous mandatory
ventilation (VC-CMV) with automode as the operating mode, all breaths are
mandatory (time triggered, volume limited, and time cycled).
If the patient begins to trigger breaths, the ventilator switches to VS (patient
triggered, pressure limited, and flow cycled with a volume target) and remains in
this mode as long as the patient is breathing spontaneously.
20. Mandatory Minute
Ventilation
the ventilator adjusts the pressure,
frequency, or the VT to maintain the
desired VE.
With traditional weaning methods (e.g.,
IMV and PSV), a
constant level of ventilation is not
guaranteed.
As a precaution,
the high respiratory rate (f) and low VT
alarms must be set appropriately.
21. Artificial Intelligence Systems
to maintain the patient in a respiratory “zone of comfort.
The patient’s readiness for extubation is based on achieving the
predefined lowest level of inspiratory pressure.
23. clinicians. In 1999 the federal Agency for Healthcare Policy and Research
(AHCPR) asked the McMaster University Outcomes Research Unit
to do a comprehensive review of the literature on ventilator withdrawal
issues to establish the evidence on which ventilator weaning is based.
a task force of the ACCP, the SCCM, and the AARC created evidence-based
guidelines for ventilator weaning for patients requiring more than
24 hours of ventilation.
24. EVALUATION OF CLINICAL CRITERIA
FOR WEANING
Three key points have evolved as criteria for weaning:
1. The problem that caused the patient to require ventilation must
have been resolved.
2. Certain measurable criteria should be assessed to help establish
a patient’s readiness for discontinuation of ventilation.
3. A spontaneous breathing trial should be performed to firmly
establish readiness for weaning.
31. Measurement of Drive to Breathe
To obtain the P0.1, the airway is occluded during the first 100
milliseconds of inspiration and the pressure at the upper airway is
measured (Fig. 20-6). The P0.1 is believed to reflect both the drive
to breathe and ventilatory muscle strength.2 The normal range is
0 to −2 cm H2O.
32. A properly monitored SBT is safe and effective; therefore the other assessments
listed under Recommendation 2 (see Box 20-4) and in Table 20-1 may generally be
unnecessary.
33. RECOMMENDATION 3: ASSESSMENT DURING
A SPONTANEOUS BREATHING TRIAL
“The best indicator of ventilator discontinuation potential is the clinical assessment
of patients during the 30- to 120-minute spontaneous breathing trial (e.g.,
respiratory rate, BP, HR, comfort/anxiety, oxygenation, SpO2).
Studies have demonstrated that 77% to 85% of patients who pass an SBT can be
successfully weaned and extubated without requiring reintubation.
The SBT can be accomplished using a low level of CPAP (e.g., 5 cm H2O), a low
level of PSV (e.g., 5 to 8 cm H2O), ATC, or simply a T-piece.
34.
35. RECOMMENDATION 4: REMOVAL
OF THE ARTIFICIAL AIRWAY
Some practitioners equate ventilator liberation with extubation .
The cuff leak test is a means of testing for post extubation airway patency.
Treatment with steroids or racemic epinephrine (or both) before extubation may
be indicated.
an extubation failure rate of 10% to 19% may be clinically acceptable.
Reintubation is marked by an eightfold higher risk for the development of
nosocomial pneumonia and a sixfold to twelvefold increase in the mortality rate.
Interestingly, up to 80% of patients who intentionally self-extubate do not require
reintubation.
36. Postextubation Difficulties
Hoarseness, sore throat, and cough are common after extubation. Other
postextubation problems include subglottic edema, increased WOB from
secretions, airway obstruction, and postextubation laryngospasm.
Subglottic edema - nebulized racemic epinephrine (0.5 mL, 2.25% epinephrine in
3 mL normal saline).
WOB – heliox therapy.
Laryngospasm – positive pressure delivered with oxygen
Non invasive Positive Pressure Ventilation After Extubation.
37. RECOMMENDATION 5: SPONTANEOUS
BREATHING TRIAL FAILURE
Clinicians should wait 24 hours before attempting subsequent spontaneous
breathing trials (SBTs) in patients for whom SBT fails.
Even twice-daily SBTs offer no advantage over testing once a day.
NONRESPIRATORY FACTORS THAT MAY COMPLICATE WEANING
40. Metabolic factors
hypophosphatemia, hypomagnesemia, and hypothyroidism – decrease muscle
strength.
Effect of Pharmacologic Agents
use of sedatives, opioids, tranquilizers, and hypnotic agents can all depress the
central ventilatory drive.
The two primary reasons for prolonged paralysis after withdrawal of NMBAs are:
(1) a reduced ability to metabolize and excrete these drugs and
(2) the development of an acute myopathy.
An acute myopathy can develop when high maintenance doses of corticosteroids
and continuous nondepolarizing agents (e.g., vecuronium or pancuronium) are
used.
41. Nutritional Status and Exercise
Increased minute ventilation
Increased carbondioxide production
Increase in oxygen consumption
Overfeeding carbohydrates
42. Psychological Factors
Unmotivated patients therefore probably will take longer to wean than those
patients who are optimistic about their recovery.
Psychological problems can manifest as fear, anxiety, delirium, ICU psychosis,
depression, anger, denial, fear of shortness of breath, and fear of being left alone,
among other symptoms.
Health care workers often go into patient areas and perform a clinical procedure or
check the equipment and never take the time to communicate with the patient.
Establishing effective communication skills is critical for achieving successful
clinical outcomes.
43. RECOMMENDATION 6: MAINTAINING
VENTILATION IN PATIENTS WITH
SPONTANEOUS BREATHING TRIAL FAILURE
Patients for whom an SBT fails should receive a stable, non fatiguing,
comfortable form of ventilatory support.
To date there is no evidence that a gradual support reduction strategy is better
than providing full, stable support between once daily SBTs.
44. RECOMMENDATION 7: ANESTHESIA AND
SEDATION STRATEGIES AND PROTOCOLS
A lower anesthetic/sedation regimen may permit earlier extubation.
45. RECOMMENDATION 8: WEANING
PROTOCOLS
Protocols for ventilator discontinuation, which are designed for nonphysician
clinicians often are called therapist-driven protocols (TDPs) or nurse-driven
protocols.
Weaning protocols have been shown to be efficient and effective approaches to
discontinuation of ventilatory support.
46.
47. RECOMMENDATION 9: ROLE OF
TRACHEOSTOMY IN WEANING
The procedure usually is performed within 7 days of the onset of respiratory
failure, or sooner in neurologically impaired patients.
A tracheostomy site typically requires 7 to 10 days to mature. If the tracheostomy
tube is inadvertently displaced in the first 24 to 72 hours, successful blind tube
replacement is highly unlikely.
48. RECOMMENDATION 10: LONG-TERM CARE
FACILITIES FOR PATIENTS REQUIRING
PROLONGED VENTILATION
exists, a patient who requires prolonged ventilatory support should not be
considered permanently ventilator dependent until 3 months have passed and all
weaning attempts during that time have failed.
49. RECOMMENDATION 11: CLINICIAN
FAMILIARITY WITH LONG-TERM
CARE FACILITIES
These facilities should have demonstrated competence, safety, and success in
accomplishing ventilator discontinuation.
50. RECOMMENDATION 12: WEANING
IN LONG-TERM VENTILATION UNITS
The following are the goals for weaning in long-term care facilities.
1. To reduce the amount of ventilatory support
2. To reduce the invasiveness of support
3. To increase independence from mechanical devices
4. To preserve and/or improve current function
5. To maintain medical stability